Commission Implementing Regulation (EU) 2025/1116 of 12 June 2025 granting a Union authorisation for the biocidal product family PAA family UCO Group in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council

Type Implementing Regulation
Publication 2025-06-12
State In force
Department European Commission, SANTE
Source EUR-Lex
Reform history JSON API

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (1), and in particular Article 44(5), first subparagraph, thereof,

Whereas:

(1) On 10 July 2024, UCO Group BV submitted an application to the European Chemicals Agency (‘the Agency’) in accordance with Article 43(1) of Regulation (EU) No 528/2012 and Article 4 of Commission Implementing Regulation (EU) No 414/2013 (2) for Union authorisation of the same biocidal product family, as referred to in Article 1 of Implementing Regulation (EU) No 414/2013, named ‘PAA family UCO Group’, of product-types 2, 3 and 4, as described in Annex V to Regulation (EU) No 528/2012. The application was recorded under case number BC-TR098628-91 in the Register for Biocidal Products. The application also indicated the authorisation number of the related reference biocidal product family ‘Airedale PAA product family’ authorised by Commission Implementing Regulation (EU) 2023/1200 (3), with authorisation number EU-0028970-0000.

(2) The biocidal product family ‘PAA family UCO Group’ contains peracetic acid as the active substance, included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 2, 3 and 4.

(3) On 14 October 2024, the Agency submitted to the Commission its opinion (4) and the draft summary of the biocidal product characteristics (‘SPC’) of ‘PAA family UCO Group’ in accordance with Article 6 of Implementing Regulation (EU) No 414/2013.

(4) In its opinion, the Agency concludes that the proposed differences between the biocidal product family ‘PAA family UCO Group’ and the reference biocidal product family ‘Airedale PAA product family’ are limited to information which can be the subject of an administrative change in accordance with Commission Implementing Regulation (EU) No 354/2013 (5), and that based on the assessment of the related reference biocidal product family ‘Airedale PAA product family’ and subject to compliance with the draft SPC, the same biocidal product family ‘PAA family UCO Group’ meets the conditions laid down in Article 19(6) of Regulation (EU) No 528/2012.

(5) On 14 October 2024, the Agency transmitted to the Commission the draft SPC of ‘PAA family UCO Group’ in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.

(6) The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for the same biocidal product family ‘PAA family UCO Group’.

(7) The expiry date of the authorisation should be aligned with the expiry date of the authorisation of the related reference biocidal product family ‘Airedale PAA product family’.

(8) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,

HAS ADOPTED THIS REGULATION:

Article 1

A Union authorisation with authorisation number EU-0033444-0000 is hereby granted to UCO Group BV for the making available on the market and use of the same biocidal product family ‘PAA family UCO Group’ in accordance with the summary of the biocidal product characteristics set out in the Annex.

The Union authorisation is valid from 8 July 2025 until 30 June 2033.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 12 June 2025.

For the Commission The President Ursula VON DER LEYEN

(1) OJ L 167, 27.6.2012, p. 1, ELI: http://data.europa.eu/eli/reg/2012/528/oj.

(2) Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure for the authorisation of same biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 125, 7.5.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/414/oj).

(3) Commission Implementing Regulation (EU) 2023/1200 of 21 June 2023 granting a Union authorisation for the biocidal product family ‘Airedale PAA product family’ (OJ L 159, 22.06.2023, p. 3, ELI: http://data.europa.eu/eli/reg_impl/2023/1200/oj).

(4) European Chemicals Agency opinion of 14 October 2024 on the Union authorisation of the of the same biocidal product family PAA family UCO Group, https://echa.europa.eu/opinions-on-union-authorisation.

(5) Commission Implementing Regulation (EU) No 354/2013 of 18 April 2013 on changes of biocidal products authorised in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council. (OJ L 109, 19.4.2013, p. 4, ELI: http://data.europa.eu/eli/reg_impl/2013/354/oj).

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.